LPL Financial
DNA icon

LPL Financial’s Ginkgo Bioworks DNA Stock Holding History

LPL Financial’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-55,000
Closed -$448K – 5325
2024
Q3 		$448K Buy
55,000
+53,625
+3,900% +$537K ﹤0.01% 4090
2024
Q2 		$18.4K Buy
+1,375
New +$41K ﹤0.01% 4939

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LPL Financial's DNA Position: Q1 2026 in Review

LPL Financial increased its Ginkgo Bioworks (DNA) stake by 38% in Q1 2026, buying an estimated $99.7K and bringing the position to 43,516 shares worth $267K. The position accounts for ﹤0.01% of the portfolio, ranked #5276.

LPL Financial first reported a position in DNA in Q3 2021 and has held it in 18 quarters since. The position peaked at $806K in Q4 2023. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • LPL Financial held 43,516 shares of Ginkgo Bioworks worth $267K as of Q1 2026.
  • LPL Financial bought 11,989 Ginkgo Bioworks shares in Q1 2026, an estimated $99.7K.
  • Ginkgo Bioworks made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5276 holding.
  • LPL Financial first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 18 quarters since.
  • LPL Financial's Ginkgo Bioworks position peaked at $806K in Q4 2023.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.